Discover the Medicines Manufacturing Innovation Centre (MMIC) and the Inhaled Oxytocin Project

The below video showcases the capabilities and services of the Medicines Manufacturing Innovation Centre (MMIC) and also introduces the Inhaled Oxytocin Project, one of the Faculty of Pharmacy and Pharmaceutical Sciences’ flagship examples of how a unique medicine formulation can have global impact. It features MMIC Director and Inhaled Oxytocin co-lead, Professor Michelle McIntosh, various members of the MMIC team and Director of the Monash Quality of Medicines Initiative and Inhaled Oxytocin co-lead, Associate Professor (Practice) Pete Lambert.

For more information about how MMIC can contribute to your organisation’s goals, visit the MMIC website.

To support the Inhaled Oxytocin Project, visit this page.

Putting research into perspective: Consumer engagement at MIPS

In early 2023 the MRFF established principles for consumer engagement which have since evolved into a mandate. MIPS looks forward to partnering with consumers across the spectrum of drug discovery, leaning on in-house expertise from members of CMUS.

Supercomputers, neural networks and quantum chemistry: How AI and quantum are transforming education and research

AI is changing education and research across the Faculty. Meet Professor Giuseppe Barca, who joined MIPS to accelerate the University’s drug discovery capabilities with his unique expertise in high-performance computing, AI and quantum chemistry.

Issue 38

Return to issue home page.